VIM and breast carcinoma: In a meta-analysis of 1107 breast cancer samples, Tobin et al. showed reduced recurrence free survival in tumors displaying increased gene expression of EMT markers SNAI2, TWIST1 and VIM, and decreased levels of CDH1 (encoding for E-cadherin) [122].